C-Reactive Protein Testing Market: How the CRP Test Is Moving Closer to the Patient
Inflammation sits behind many chronic and infectious conditions, and one of the simplest ways to measure it is a CRP blood test. The C-reactive protein testing market is expanding as clinicians look for quick, reliable markers to support diagnosis and monitoring. Polaris Market Research reports that the market was valued at USD 2.9 billion in 2024, is estimated at USD 3.16 billion in 2025 and is projected to reach USD 6.7 billion by 2034, a CAGR of 8.80% from 2025 to 2034.
Why Demand Is Growing
A CRP test measures the level of C-reactive protein in the blood, which rises when inflammation is present. It supports the assessment of infections and inflammatory disorders such as rheumatoid arthritis, lupus and inflammatory bowel disease, and it helps evaluate cardiovascular risk. Because the marker is not specific to one condition, results are normally read alongside other clinical findings. The World Health Organization reported that about 17.9 million people died from cardiovascular diseases in 2019, around 32% of global deaths, and that burden, together with aging populations and rising healthcare spending, keeps testing volumes growing.
Key Industry Trends
High-Sensitivity Testing
The hs CRP test detects even small increases in CRP and is valuable for identifying coronary artery disease risk. Polaris expects the high-sensitivity segment to grow fastest during the forecast period, helped by newer biosensor technologies and point-of-care devices. Among assay types, immunoturbidimetric assays held the largest revenue share in 2024.
Point-of-Care Speed
Rapid testing is changing where a CRP blood test happens. Abbott’s Afinion CRP delivers results in about three minutes, and Aidian offers the QuikRead go CRP system with a portable instrument. Tools like these suit clinics, assisted living facilities and home care settings, where fast answers support quicker decisions.
AI and Automation
Polaris also points to artificial intelligence as a growing influence. AI can automate interpretation, cross-reference results with patient history and streamline laboratory workflows. In September 2025, HORIBA announced a partnership with GeodAIsics on an AI-driven solution for early sepsis detection using CRP-enabled analyzers, and in August 2025 Quest Diagnostics completed the acquisition of select clinical testing assets from Spectra Laboratories.
Regional and Cost Considerations
North America held the largest share in 2024 because of the high burden of cardiovascular disease and advanced healthcare facilities, while Asia Pacific is expected to grow fastest as the senior population rises in Japan and China. The main restraints are high costs and the lack of standardized reimbursement, so a CRP test remains harder to access in some settings.
COVID-19 and Infection Monitoring
The COVID-19 pandemic raised the profile of CRP testing. Guidance from the International Federation of Clinical Chemistry and Laboratory Medicine describes C-reactive protein as a marker for evaluating the severity of infections and monitoring treatment progress, and Chinese guidelines recommend using it with other clinical parameters when following SARS-CoV-2 disorder. Heightened use in research and clinical settings during the pandemic is expected to keep supporting the market.
Browse In-depth Market Research Report:
https://www.polarismarketresearch.com/industry-analysis/c-reactive-protein-testing-market
Innovation in Assay Design
Researchers are developing new assays and biosensors to make CRP measurement faster and more precise. A 2021 study from an Indian diagnostics company described a latex-enhanced immunoturbidimetric method for highly sensitive, wide-range detection in serum, and research from Korea has reviewed electrical and electrochemical biosensors built with nanomaterial hybrids. Such work is expected to encourage end users to adopt more advanced tools.
Key Players
Companies active in the CRP testing market include:
- Abbott
- Aidian
- Hoffmann-La Roche Ltd.
- Siemens Healthineers AG
- Thermo Fisher Scientific
- HORIBA, Ltd.
- Randox Laboratories Ltd.
- Quest Diagnostics
- Laboratory Corporation of America Holdings
- Merck KGaA
Conclusion
The C-reactive protein testing market is gaining strength from heart disease, aging populations and the demand for faster diagnostics. As the hs CRP test spreads and point-of-care systems become easier to use, the standard CRP blood test is likely to reach more patients in more settings. Companies that pair accurate assays with automation, clear reimbursement strategies and efficient laboratory workflows will be best placed to benefit.
More Trending Latest Reports By Polaris Market Research:
Clinical Laboratory Tests Market Trends
Customized Premixes Market Size
Oncology Information Systems Market Growth
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Jogos
- Gardening
- Health
- Início
- Literature
- Music
- Networking
- Outro
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness